GLP-1 Receptor Agonist Market Size, Share & Trends Report

GLP-1 Receptor Agonist Market Size, Share & Trends Analysis Report By Type (Victoza, Ozempic, Saxenda, Trulicity, Bydureon), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

  • Published Date: Jun 2020
  • Report ID: GVR-4-68038-694-3
  • Number of Pages: 185
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2018

Table of Contents

Chapter 1. Methodology and Scope
                 1.1.Market Segmentation & Scope
                 1.2. MarketDefinition
                 1.3. InformationProcurement
                     1.3.1. Purchased database
                     1.3.2. GVR’s internal database
                     1.3.3. Secondary sources & Third-party perspectives
                     1.3.4. Primary research
                 1.4. Information Analysis
                     1.4.1. Data analysis models
                 1.5. Market Formulation & Data Visualization
                 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
                 2.1. Market Outlook
                 2.2. Segment Outlook
                 2.3. Competitive Insights
Chapter 3. GLP - 1 Receptor Agonist Market Variables, Trends & Scope
                 3.1. Penetration & Growth Prospect Mapping
                 3.2. Regulatory Framework
                     3.2.1. Reimbursement framework
                 3.3. Market Dynamics
                     3.3.1. Market driver analysis
                         3.3.1.1. Formulation advancements of GLP - 1 receptor agonist
                         3.3.1.2. Presence of strong product pipeline
                         3.3.1.3. Favorable reimbursement policies
                         3.3.1.4. Increase in the prevalence rate of lifestyle diseases
                     3.3.2. Market restraint analysis
                         3.3.2.1. Product failure
                         3.3.2.2. Patent expiry of blockbuster drugs during the forecast period
                 3.4. GLP - 1 Receptor Agonist Market Analysis Tools
                     3.4.1. Industry Analysis - Porter’s
                         3.4.1.1. Supplier power (Moderate due to the requirement of high - quality raw materials)
                         3.4.1.2. Buyer power (High due to a limited number of established providers)
                         3.4.1.3. Substitution threat (Low due to clinical development of new compounds)
                         3.4.1.4. New entrants’ threat (Moderate as the market is underserved)
                         3.4.1.5. Competitive rivalry (Moderate due to presence of few key players)
                     3.4.2. PESTEL analysis
                         3.4.2.1. Political landscape
                         3.4.2.2. Environmental landscape
                         3.4.2.3. Social landscape
                         3.4.2.4. Technology landscape
                         3.4.2.5. Legal landscape
                     3.4.3. Major deals & strategic alliances analysis
                         3.4.3.1. Joint ventures
                         3.4.3.2. Mergers & acquisitions
Chapter 4. GLP - 1 Receptor Agonist Market - Competitive Analysis
                 4.1. Recent Developments & Impact Analysis, by Key Market Participants
                 4.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)
                 4.3. Public Companies
                     4.3.1. Company market position analysis (Revenue, geographic presence, product portfolio, key serviceable industries, key alliances)
                     4.3.2. Company market share
                     4.3.3. Synergy analysis: Major deals & strategic alliances
                 4.4. Private Companies
                     4.4.1. List of key emerging companies
                     4.4.2. Regional network map
                     4.4.3. Company market position analysis (geographic presence, product portfolio, key alliance, industry experience)
Chapter 5. GLP - 1 Receptor Agonist Market: Type Estimates & Trend Analysis
                 5.1. Definitions & Scope
                 5.2. DrugMarket Share Analysis, 2019 & 2027
                 5.3. GLP - 1 Receptor Agonist Market, byType, 2016 to 2027
                 5.4. Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the following,
                     5.4.1. Victoza
                         5.4.1.1 Victoza market, 2016 - 2027 (USD Million)
                     5.4.2. Ozempic
                         5.4.2.1 Ozempic market, 2016 - 2027 (USD Million)
                     5.4.3. Trulicity
                         5.4.3.1 Trulicity market, 2016 - 2027 (USD Million)
                     5.4.4. Bydureon
                         5.4.4.1 Bydureon market, 2016 - 2027 (USD Million)
                     5.4.5. Saxenda
                         5.4.5.1 Saxenda market, 2016 - 2027 (USD Million)
                     5.4.6. Others
                         5.4.6.1 Others market, 2016 - 2027 (USD Million)
Chapter 6 GLP - 1 Receptor Agonist Market: Regional Estimates & Trend Analysis, by Type
                 6.1 GLP - 1 Receptor Agonist Market: Regional Movement Analysis, 2018 & 2026
                 6.2 GLP - 1 Receptor Agonist Market: Leading Players, 2018:
                     6.2.1. North America
                     6.2.2. Europe
                     6.2.3. Asia Pacific
                     6.2.4. Latin America
                     6.2.5. Middle East & Africa
                 6.3 SWOT Analysis, by Factor (Political & Legal, Economic And Technological)
                     6.3.1. North America
                     6.3.2. Europe
                     6.3.3. Asia Pacific
                     6.3.4. Latin America
                     6.3.5. Middle East & Africa
                 6.4 North America
                     6.4.1 North America market, 2016 - 2027 (USD Million)
                     6.4.2 U.S.
                         6.4.2.1 U.S. market, 2016 - 2027 (USD Million)
                     6.4.3 Canada
                         6.4.3.1 Canada market, 2016 - 2027 (USD Million)
                 6.5. Europe
                     6.5.1 Europe market, 2016 - 2027 (USD Million)
                     6.5.2 U.K.
                         6.5.2.1 U.K. market, 2016 - 2027 (USD Million)
                     6.5.3 Germany
                         6.5.3.1 Germany market, 2016 - 2027 (USD Million)
                     6.5.4 France
                         6.5.4.1 France market, 2016 - 2027 (USD Million)
                     6.5.5 Spain
                         6.5.5.1 Spain market, 2016 - 2027 (USD Million)
                     6.5.6 Italy
                         6.5.6.1 Italy market, 2016 - 2027 (USD Million)
                 6.6 Asia Pacific
                     6.6.1 Asia Pacific market, 2016 - 2027 (USD Million)
                     6.6.2 Japan
                         6.6.2.1 Japan market, 2016 - 2027 (USD Million)
                     6.6.3 China
                         6.6.3.1 China market, 2016 - 2027 (USD Million)
                     6.6.4 Australia
                         6.6.4.1 Australia market, 2016 - 2027 (USD Million)
                     6.6.5 South Korea
                         6.6.5.1 South Korea market, 2016 - 2027 (USD Million)
                 6.7 Latin America
                     6.7.1 Latin America market, 2016 - 2027 (USD Million)
                     6.7.2 Brazil
                         6.7.2.1 Brazil market, 2016 - 2027 (USD Million)
                     6.7.3 Mexico
                         6.7.3.1 Mexico market, 2016 - 2027 (USD Million)
                     6.7.4 Argentina
                         6.7.4.1 Argentina market, 2016 - 2027 (USD Million)
                 6.8 Middle East & Africa
                     6.8.1 Middle East & Africa market, 2016 - 2027 (USD Million)
                     6.8.2 South Africa
                         6.8.2.1 South Africa market, 2016 - 2027 (USD Million)
                     6.8.3 Saudi Arabia
                         6.8.3.1 Saudi Arabia market, 2016 - 2027 (USD Million)
Chapter 7 Competitive Landscape
                 7.1 Strategy Framework
                 7.2 Heat Map Analysis of Private Companies
                     7.2.1 Company size
                     7.2.2 Distribution network
                     7.2.3 Product portfolio
                     7.2.4 Segment coverage
                     7.2.5 Geographic presence
                     7.2.6 Collaborations
                     7.2.7 Conclusion
                 7.3 Eli Lilly and Company
                     7.3.1 Company overview
                     7.3.2 Financial performance
                     7.3.3 Product benchmarking
                     7.3.4 Strategic initiatives
                 7.4 Sanofi
                     7.4.1 Company overview
                     7.4.2 Financial performance
                     7.4.3 Product benchmarking
                     7.4.4 Strategic initiatives
                 7.5 Novo Nordisk A/S
                     7.5.1 Company overview
                     7.5.2 Financial performance
                     7.5.3 Product benchmarking
                     7.5.4 Strategic initiatives
                 7.6 AstraZeneca
                     7.6.1 Company overview
                     7.6.2 Financial performance
                     7.6.3 Product benchmarking
                     7.6.4 Strategic initiatives


List of Tables

TABLE 1 Country share estimation
TABLE 2 North America GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 3 U.S. GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 4 Canada GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 5 Europe GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 6 U.K. GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 7 Germany GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 8 France GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 9 Spain GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 10 Italy GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 11 Asia Pacific GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 12 Japan GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 13 China GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 14 Australia GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 15 South Korea GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 16 Latin America GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 17 BrazilGLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 18 Mexico GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 19 Argentina GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 20 Middle East & Africa GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 21 South Africa GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)
TABLE 22 Saudi Arabia GLP-1 receptor agonist market estimates and forecasts, by product, 2016 - 2027 (USD Million)


List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Market summary, 2018
FIG. 4 Market trends & outlook
FIG. 5 Market segmentation & scope
FIG. 6 Market driver relevance analysis (Current & future impact)
FIG. 7 Market restrain relevance analysis (Current & future impact)
FIG. 8 Penetration & growth prospect mapping
FIG. 9 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 10 Porter’s five forces analysis
FIG. 11 GLP-1 receptor agonist market Product outlook key takeaways
FIG. 12 GLP-1 receptor agonist market: Product movement analysis
FIG. 13 Global GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 14 Regional market place: Key takeaways, 2019
FIG. 15 Regional outlook, 2019 & 2027
FIG. 16 North America GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 17 U.S. GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 18 Canada GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 19 Europe GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 20 U.K.GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 21 Germany GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 22 FranceGLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 23 Spain GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 24 ItalyGLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 25 Asia Pacific GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 26 JapanGLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 27 ChinaGLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 28 AustraliaGLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 29 South Korea GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 30 Latin America GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 31 BrazilGLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 32 Mexico GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 33 Argentina GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 34 Middle East and Africa GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 35 South Africa GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 36 Saudi Arabia GLP-1 receptor agonist market, 2016 - 2027 (USD Million)
FIG. 37 Strategy framework
FIG. 38 Participant categorization

What questions do you have? Get quick response from our industry experts. Request a Free Consultation
gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.